These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3464268)

  • 1. Effects of cholinergic enhancement therapies on memory function in Alzheimer's disease: a meta-analysis of the literature.
    Jorm AF
    Aust N Z J Psychiatry; 1986 Jun; 20(2):237-40. PubMed ID: 3464268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cholinergic treatment strategies in Alzheimer's disease].
    Kurz A; Rüster P; Romero B; Zimmer R
    Nervenarzt; 1986 Oct; 57(10):558-69. PubMed ID: 3785472
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of Alzheimer's disease with cholinergic drugs.
    Kumar V; Calache M
    Int J Clin Pharmacol Ther Toxicol; 1991 Jan; 29(1):23-37. PubMed ID: 2004862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic drug studies in dementia and depression.
    Newhouse PA
    Adv Exp Med Biol; 1990; 282():65-76. PubMed ID: 2088086
    [No Abstract]   [Full Text] [Related]  

  • 5. Measurement of cholinergic drug effects on memory in Alzheimer's disease.
    Brinkman SD; Gershon S
    Neurobiol Aging; 1983; 4(2):139-45. PubMed ID: 6355883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cholinergic and anticholinergic drugs on short-term memory in Alzheimer's dementia: a neuropsychological and computerized electroencephalographic study.
    Agnoli A; Martucci N; Manna V; Conti L; Fioravanti M
    Clin Neuropharmacol; 1983; 6(4):311-23. PubMed ID: 6661730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple memory deficits in Alzheimer-type dementia: implications for pharmacotherapy.
    Kopelman MD
    Psychol Med; 1985 Aug; 15(3):527-41. PubMed ID: 4048315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of cholinergic preparations in Alzheimer's disease].
    Bradley RJ; Edge MT; Freeman AM
    Farmakol Toksikol; 1991; 54(3):4-10. PubMed ID: 1915820
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cholinergic agents in the treatment of Alzheimer's disease].
    Zemishlany Z; Davidson M; Davis KL
    Harefuah; 1987 Dec; 113(12):401-4. PubMed ID: 3330722
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholinergic drugs in Alzheimer's disease.
    Davis KL; Mohs RC
    N Engl J Med; 1986 Nov; 315(20):1286-7. PubMed ID: 3773941
    [No Abstract]   [Full Text] [Related]  

  • 11. The treatment of cognitive impairment in Alzheimer's disease: beyond the cholinergic approach.
    Davidson M; Stern RG
    Psychiatr Clin North Am; 1991 Jun; 14(2):461-82. PubMed ID: 2062728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Alzheimer's disease: hopes and reality.
    Gauthier S; Gauthier L; Bouchard R; Quirion R; Sultan S
    Can J Neurol Sci; 1991 Aug; 18(3 Suppl):439-41. PubMed ID: 1933695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic treatments for Alzheimer's disease.
    Roberts F; Lazareno S
    Biochem Soc Trans; 1989 Feb; 17(1):76-9. PubMed ID: 2653922
    [No Abstract]   [Full Text] [Related]  

  • 14. Are drugs targeted at Alzheimer's disease useful? 2. Insufficient evidence of worthwhile benefit.
    Byrne EJ; Arie T
    BMJ; 1990 Apr; 300(6732):1132-3; discussion 1131. PubMed ID: 2160850
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholinergic approaches to the treatment of Alzheimer's disease.
    Hollander E; Mohs RC; Davis KL
    Br Med Bull; 1986 Jan; 42(1):97-100. PubMed ID: 3006861
    [No Abstract]   [Full Text] [Related]  

  • 16. Can drugs improve memory?
    Kent S
    Geriatrics; 1979 Jul; 34(7):77, 80, 83 passim. PubMed ID: 376407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential response to the cholinergic agonist arecoline among different cognitive modalities in Alzheimer's disease.
    Raffaele KC; Asthana S; Berardi A; Haxby JV; Morris PP; Schapiro MB; Soncrant TT
    Neuropsychopharmacology; 1996 Aug; 15(2):163-70. PubMed ID: 8840352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaches to cholinergic therapy in Alzheimer's disease.
    Iversen LL
    Prog Brain Res; 1993; 98():423-6. PubMed ID: 8248531
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of physostigmine on memory and auditory P300 in Alzheimer-type dementia.
    Blackwood DH; Christie JE
    Biol Psychiatry; 1986 May; 21(5-6):557-60. PubMed ID: 3697444
    [No Abstract]   [Full Text] [Related]  

  • 20. Intracranial drug administration in Alzheimer's disease.
    Harbaugh RE
    Psychopharmacol Bull; 1986; 22(1):106-9. PubMed ID: 3726055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.